D.E. Shaw & Co
TXG icon

D.E. Shaw & Co’s 10x Genomics TXG Stock Holding History

D.E. Shaw & Co’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Sell
68,557
-105,911
-61% -$2.12M ﹤0.01% 3158
2025
Q4 		$2.85M Buy
174,468
+11,560
+7% +$175K ﹤0.01% 2763
2025
Q3 		$1.9M Sell
162,908
-583,358
-78% -$7.61M ﹤0.01% 3015
2025
Q2 		$8.64M Sell
746,266
-1,235,997
-62% -$11.3M 0.01% 1604
2025
Q1 		$17.3M Buy
1,982,263
+763,665
+63% +$9.63M 0.02% 1036
2024
Q4 		$17.5M Buy
+1,218,598
New +$19.2M 0.01% 1111
2024
Q2 		– Sell
-64,799
Closed -$2.43M – 4858
2024
Q1 		$2.43M Buy
64,799
+59,855
+1,211% +$2.63M ﹤0.01% 2477
2023
Q4 		$277K Sell
4,944
-55,361
-92% -$2.41M ﹤0.01% 3770
2023
Q3 		$2.49M Sell
60,305
-47,225
-44% -$2.46M ﹤0.01% 2399
2023
Q2 		$6M Buy
107,530
+97,299
+951% +$5.27M 0.01% 1725
2023
Q1 		$571K Sell
10,231
-184,026
-95% -$8.59M ﹤0.01% 3494
2022
Q4 		$7.08M Buy
+194,257
New +$6.35M 0.01% 1767
2021
Q4 		– Sell
-3,402
Closed -$495K – 5726
2021
Q3 		$495K Sell
3,402
-32,334
-90% -$5.55M ﹤0.01% 4088
2021
Q2 		$7M Sell
35,736
-55,177
-61% -$9.99M 0.01% 1774
2021
Q1 		$16.5M Sell
90,913
-115,104
-56% -$19.9M 0.02% 1041
2020
Q4 		$29.2M Buy
206,017
+63,898
+45% +$9.27M 0.03% 760
2020
Q3 		$17.7M Buy
+142,119
New +$14.9M 0.02% 899
2020
Q2 		– Sell
-10,973
Closed -$684K – 4264
2020
Q1 		$684K Buy
10,973
+6,970
+174% +$544K ﹤0.01% 3020
2019
Q4 		$305K Buy
+4,003
New +$241K ﹤0.01% 3620

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's TXG Position: Q1 2026 in Review

D.E. Shaw & Co reduced its 10x Genomics (TXG) stake by 61% in Q1 2026, selling an estimated $2.12M and leaving 68,557 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

D.E. Shaw & Co first reported a position in TXG in Q4 2019 and has held it in 19 quarters since. The position peaked at $29.2M in Q4 2020. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • D.E. Shaw & Co held 68,557 shares of 10x Genomics worth $1.46M as of Q1 2026.
  • D.E. Shaw & Co sold 105,911 10x Genomics shares in Q1 2026, an estimated $2.12M.
  • 10x Genomics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3158 holding.
  • D.E. Shaw & Co first reported a position in 10x Genomics in Q4 2019 and has held it in 19 quarters since.
  • D.E. Shaw & Co's 10x Genomics position peaked at $29.2M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.